{"title":"Bandelette urinaire chez le patient hospitalisé : aide diagnostique ou source de confusion ?","authors":"Jean Regina","doi":"10.53738/REVMED.2025.21.912.711","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.912.711","url":null,"abstract":"","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 912","pages":"711"},"PeriodicalIF":0.0,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143772284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Health democracy and the role of law: challenges and perspectives].","authors":"Mélanie Levy","doi":"10.53738/REVMED.2025.21.912.680","DOIUrl":"10.53738/REVMED.2025.21.912.680","url":null,"abstract":"<p><p>Health democracy involves the participation of citizens and patients in health-related decisions, thereby strengthening legitimacy and transparency. In Switzerland, this model currently relies mainly on direct democracy tools such as popular initiatives and referendums. However, these mechanisms have limitations, particularly in terms of representativeness. This article explores these challenges and proposes ways to strengthen health democracy by improving participation both upstream and downstream of the legislative process, integrating currently marginalized groups, and using digital tools to enable more inclusive and effective participation.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 912","pages":"680-683"},"PeriodicalIF":0.0,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143773313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[\"Talking commits to nothing but listening compels\": participatory mechanisms in question].","authors":"Nelly Sénac, Christina Akre","doi":"10.53738/REVMED.2025.21.912.695","DOIUrl":"10.53738/REVMED.2025.21.912.695","url":null,"abstract":"<p><p>Nicolas Rio shared his expertise on participatory democracy during a symposium and workshop on health democracy at Unisanté in August 2024. This article returns to the three key questions discussed: Does social participation make it possible to (re)establish representation for all citizen-actors? What should be the purpose of participatory mechanisms? Isn't the crisis of democracy the result of a crisis of listening rather than one of speaking? Rio's analysis highlights the limits of current systems and suggests ways to improve their impact on public policy formulation and increasing the trust of citizen-actors in their institutions. Although this approach is not limited to health, its conclusions should help stimulate reflection in this arena.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 912","pages":"695-698"},"PeriodicalIF":0.0,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143773278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Democracy and health insurance reform in Switzerland].","authors":"Philipp Trein","doi":"10.53738/REVMED.2025.21.912.684","DOIUrl":"10.53738/REVMED.2025.21.912.684","url":null,"abstract":"<p><p>This article examines the challenges of health insurance reform in Switzerland from a political science perspective. Despite increasing pressure due to rising insurance premiums, major reforms of the system remain difficult to implement. The analysis highlights three mechanisms that hinder these reforms: the institutionalization of the system, which stabilizes existing policies; the role of voters, whose choices are influenced by social and identity factors rather than objective analysis; and the conservative bias of politicians, who often underestimate public support for structural changes. This article thus underscores the inherent constraints of democracy in the field of health policy and the importance of institutional and behavioral dynamics in shaping reforms.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 912","pages":"684-687"},"PeriodicalIF":0.0,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143773299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eglė Janušonytė, Dayana Jaramillo Loaiza, Peter Jandus
{"title":"[Multiple hypersensitivity versus multiple intolerance to drugs].","authors":"Eglė Janušonytė, Dayana Jaramillo Loaiza, Peter Jandus","doi":"10.53738/REVMED.2025.21.912.660","DOIUrl":"10.53738/REVMED.2025.21.912.660","url":null,"abstract":"<p><p>In everyday practice, many patients experience reactions to substances from different drug families. Multiple Drug Hypersensitivity Syndrome (MDHS) and Multiple Drug Intolerance Syndrome (MDIS) both involve reactions to several unrelated drugs but differ in pathophysiology and clinical presentation. Rare and immune-mediated, MDHS involves T lymphocytes and presents with severe delayed exanthems, eosinophilia, and moderate hepatic cytolysis triggered by at least two chemically distinct drugs. In contrast, MDIS is a diagnosis of exclusion, characterized by adverse reactions-often pseudoallergic and immediate-to three or more unrelated drugs, occurring upon separate exposures with negative allergy tests.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 912","pages":"660-663"},"PeriodicalIF":0.0,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143773333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Rhinite allergique : la supériorité du traitement intranasal par rapport au traitement oral.","authors":"Gaël Grandmaison","doi":"10.53738/REVMED.2025.21.912.710","DOIUrl":"https://doi.org/10.53738/REVMED.2025.21.912.710","url":null,"abstract":"","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 912","pages":"710"},"PeriodicalIF":0.0,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143773089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Omalizumab for the treatment of food allergies in adults].","authors":"Morgane Schwab, Haïg Nigolian, Thomas Harr","doi":"10.53738/REVMED.2025.21.912.671","DOIUrl":"10.53738/REVMED.2025.21.912.671","url":null,"abstract":"<p><p>The growing prevalence of food allergies has social and economic impact. Therapeutic options are limited, with food avoidance remaining the main approach. Omalizumab, an anti-IgE monoclonal antibody approved for asthma, nasal polyposis, and chronic spontaneous urticaria, shows promise in treating food allergies. However, this costly treatment requires ongoing administration with an undefined duration and does not allow for the cessation of food avoidance. Further research is needed to define its indications and assess its long-term impact.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 912","pages":"671-674"},"PeriodicalIF":0.0,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143773360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Physiopathology and management of chronic urticaria].","authors":"Johan Schwab, Florian Stehlin, Yannick D Muller","doi":"10.53738/REVMED.2025.21.912.642","DOIUrl":"10.53738/REVMED.2025.21.912.642","url":null,"abstract":"<p><p>Chronic urticaria manifests as itchy, transient and migrating wheals and/or angioedema lasting more than 6 weeks. It can be classified as spontaneous or inducible by physical factors. It is secondary to mast cell activation due to autoallergy (type I) or autoimmunity (type IIb). While the initial work-up consists essentially in evaluating the presence of biomarkers, it can be completed according to comorbidities and factors identified with history and physical examination. Second generation antihistamines up to four-times the standard dose are the cornerstone of the management. This initial management can be undertaken by primary care physicians. Specialists should be involved in the presence of physical factors, resistance to antihistamines, or atypical lesions.</p>","PeriodicalId":21286,"journal":{"name":"Revue medicale suisse","volume":"21 912","pages":"642-647"},"PeriodicalIF":0.0,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143772281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}